ok if ive reconstructed the timeline correctly
it appears i got convinced to do my current dosage of CPA (~12.5mg) in 2019 based on the recommendations of a bunch of internet weirdos when there were no studies of this dosage in trans people? (historically 25-50mg or more)
it appears the internet weirdos have not manage to quite make bicalutamide a thing, tbh i suspect googling around enzalutamide will become a thing when it comes off patent in a few years
like the wikipedia says the main scary side effect is a 1% risk of seizures but i feel like we'll probably need like a tenth of the dose they ran the experiment on
and assuming the risk falls linearly we're in buproprion territory here
(note that aiui the risk falls a lot faster than linearly for buproprion)
and it appears since then a bunch of studies have come out and WPATH has endorsed the views of the internet weirdos and now thinks 10mg is best